Results 41 to 50 of about 1,156,434 (264)

Effects of Cancer Treatment on Somatosensory and Nociceptive Processing in Children and Adolescents: A Systematic Review

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Chemotherapy‐induced peripheral neuropathy remains a major complication in pediatric cancer, with disrupted somatosensory and nociceptive processing being a key aspect. This review synthesizes empirical studies on alterations in somatosensory and nociceptive processing in children and adolescents with cancer.
Julia Schweiger   +4 more
wiley   +1 more source

Maximum degree and minimum degree spectral radii of some graph operations

open access: yesMathematical Biosciences and Engineering, 2022
<abstract><p>New results relating to the maximum and minimum degree spectral radii of generalized splitting and shadow graphs have been constructed on the basis of any regular graph, referred as base graph. In particular, we establish the relations of extreme degree spectral radii of generalized splitting and shadow graphs of any regular ...
Xiujun Zhang   +3 more
openaire   +3 more sources

Results of the Childhood Cancer and Leukaemia Group's United Kingdom Relapsed Wilms Tumour Trial

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background The United Kingdom relapsed Wilms tumour (UKW‐R) trial aimed to improve the historically low survival rates after relapse of Wilms tumour (WT) through a prospective national risk‐stratified protocol. The trial also evaluated efficacy and toxicity of high‐dose melphalan.
Sucheta J. Vaidya   +10 more
wiley   +1 more source

Independence number in graphs and its upper bounds [PDF]

open access: yesJournal of Mahani Mathematical Research
‎In this paper, we use the double counting method to find some upper bounds for the independence number of a simple graph in terms of its order, size and  maximum degree.   Moreover,  we determine extremal graphs attaining equality in upper bounds.
Farzad Shaveisi
doaj   +1 more source

Efficacy and Tolerability of Topotecan/Cyclophosphamide/Dinutuximab in Relapsed and Refractory High‐Risk Neuroblastoma: A Multi‐Institutional Retrospective Study

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Purpose Chemoimmunotherapy with irinotecan, temozolomide, and dinutuximab (I/T/DIN) has emerged as first‐line therapy for relapsed/refractory (r/r) high‐risk neuroblastoma (HRNB) in North America. Topotecan and cyclophosphamide (T/C) are often used in combination with dinutuximab in the setting of lack of response, progression, or incomplete ...
Benjamin J. Lerman   +17 more
wiley   +1 more source

Clinical Course and Impact of Breaks in Therapy for Children With Relapsed/Refractory Solid Tumors

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Introduction Pediatric relapsed or refractory (R/R) solid tumors carry a dismal prognosis, and postrelapse patient experiences are not well described. We present postrelapse outcomes, including number of R/R events and subsequent therapy regimens.
Matthew T. McEvoy   +5 more
wiley   +1 more source

Clique-transversal sets and weak 2-colorings in graphs of small maximum degree [PDF]

open access: yesDiscrete Mathematics & Theoretical Computer Science, 2009
Graphs and ...
Gábor Bacsó, Zsolt Tuza
doaj   +1 more source

Random graph processes with maximum degree $2$

open access: yesThe Annals of Applied Probability, 1997
zbMATH Open Web Interface contents unavailable due to conflicting licenses.
Ruciński, A., Wormald, N. C.
openaire   +3 more sources

Criterion‐Related Validity of the Neuropsychological Quick Assessment for Screening Cognitive, Motor, and Behavioral Impairments in Patients With Pediatric Brain Tumors: An Observational Pilot Study

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Neuropsychological complications may impair the qualitative prognosis of patients with pediatric brain tumors. However, multifaceted evaluations cannot be conducted in all patients because they are time consuming and burdensome for patients.
Ami Tabata   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy